Vestal Point Capital, LP Geron Corp Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Geron Corp stock. As of the latest transaction made, Vestal Point Capital, LP holds 22,005,340 shares of GERN stock, worth $34.3 Million. This represents 2.5% of its overall portfolio holdings.
Number of Shares
22,005,340
Previous 11,000,000
100.05%
Holding current value
$34.3 Million
Previous $38.9 Billion
10.15%
% of portfolio
2.5%
Previous 2.31%
Shares
4 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$94.2 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$72.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$59.6 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$53.3 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$42.5 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $589M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...